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Background
Oligoarticular JIA encompasses two distinguished sub-
type: persistent oligoarthritis and extended oligoarthritis.
To stop the inflammatory process with poor systemic
side effects IAC therapy was proposed and now this is
the first choice therapy.
Aim
To evaluate the efficacy of the intra-articular corticoster-
oid therapy (IAC) in 62 patients affected by oligo-articu-
lar JIA.
Patients and methods
62 patients affected by oligoarticular JIA that referred to
our Departments in the period between December 2004
and June 2008, were included in the study. 34 cases
(54%) had persistent oligoarthritis and the only affected
joints were knee (45%) and ankle (9%). The remaining
patients presented extended oligoarthritis and the
involved joints, in addition to knee and ankle, were
elbow (3%), wrist (3%), interphalangeal (6%). Triamcino-
lone hexacetonide and Methylprednisolone acetate were
used. Patients were followed up for three years. MTX
was started only if NSAIDs and IAC failed. Clinical pat-
tern and serologic data, such as ESR and ANAs, were
evaluated in order to correlate them with treatment
response to predict the outcome of IAC procedure.
Results
The early treatment is more likely to determine a pro-
tracted response. Remission time is longer in persistent
oligoarthritis, while is limited in the extended form. In
presence of ANA positivity, prolonged remission is less
likely.
Conclusions
IAC determines long-lasting remission in the persistent
JIA while it induces symptomatic relieve in the extended
form. It seems that the associated systemic treatment
could prolong the benefit duration. If an extended
articular involvement occurs early it is proper to start
systemic therapy.
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